FDA panel questions the benefits of ReGen’s Menaflex meniscus repair implant

  FDA Panel Questions Knee Device  ...WSJ Online An FDA panel of outside experts found that there isn't enough scientific evidence to come to a firm conclusion about the benefits of a knee device approved by the FDA in 2008.  The panel's statement highlights the agency's dilemma as it weighs whether it has authority to revoke a device's approval.

The chairman of the panel, orthopedic surgeon John Kelly of the University of Pennsylvania, cited inadequate and low-quality evidence about the effectiveness of the Menaflex implant made by ReGen Biologics Inc., and not enough information about the ...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top